Yu X, Duan G, Pei P, Chen L, Gu R, Hu W
Elife. 2024; 13.
PMID: 38949655
PMC: 11216747.
DOI: 10.7554/eLife.93871.
Shokri F, Mozdarani H, Omrani M
Int J Mol Cell Med. 2023; 11(3):244-259.
PMID: 37605739
PMC: 10440003.
DOI: 10.22088/IJMCM.BUMS.11.3.244.
McCarty E, Yu J, Ninh V, Calcagno D, Lee J, King K
Front Immunol. 2023; 14:1199730.
PMID: 37275883
PMC: 10232813.
DOI: 10.3389/fimmu.2023.1199730.
Lenz M, Schonbauer R, Stojkovic S, Lee J, Gatterer C, Lichtenauer M
Int J Environ Res Public Health. 2022; 19(14).
PMID: 35886510
PMC: 9316936.
DOI: 10.3390/ijerph19148658.
Jacobs I, Ceulemans M, Wauters L, Breynaert C, Vermeire S, Verstockt B
Front Immunol. 2021; 12:754413.
PMID: 34737752
PMC: 8560962.
DOI: 10.3389/fimmu.2021.754413.
Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection.
Hashemi S, Thijssen M, Hosseini S, Tabarraei A, Pourkarim M, Sarvari J
Arch Virol. 2021; 166(8):2089-2108.
PMID: 33934196
PMC: 8088757.
DOI: 10.1007/s00705-021-05070-6.
The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma.
Bai S, Wu Y, Yan Y, Kang H, Zhang J, Ma W
Int J Med Sci. 2020; 17(18):2917-2925.
PMID: 33173412
PMC: 7646109.
DOI: 10.7150/ijms.51126.
Bioinformatic Identification of Neuroblastoma Microenvironment-Associated Biomarkers with Prognostic Value.
Wang Y, Luo H, Cao J, Ma C
J Oncol. 2020; 2020:5943014.
PMID: 32963529
PMC: 7501561.
DOI: 10.1155/2020/5943014.
Screening TCGA database for prognostic genes in lower grade glioma microenvironment.
Ni J, Liu S, Qi F, Li X, Yu S, Feng J
Ann Transl Med. 2020; 8(5):209.
PMID: 32309356
PMC: 7154476.
DOI: 10.21037/atm.2020.01.73.
A Comprehensive Review of Alzheimer's Association with Related Proteins: Pathological Role and Therapeutic Significance.
Kumar D, Sharma A, Sharma L
Curr Neuropharmacol. 2020; 18(8):674-695.
PMID: 32172687
PMC: 7536827.
DOI: 10.2174/1570159X18666200203101828.
MicroRNAs expressed by human cytomegalovirus.
Zhang L, Yu J, Liu Z
Virol J. 2020; 17(1):34.
PMID: 32164742
PMC: 7069213.
DOI: 10.1186/s12985-020-1296-4.
Effects of CCL5 on the biological behavior of breast cancer and the mechanisms of its interaction with tumor‑associated macrophages.
An G, Wu F, Huang S, Feng L, Bai J, Gu S
Oncol Rep. 2019; 42(6):2499-2511.
PMID: 31578575
PMC: 6826325.
DOI: 10.3892/or.2019.7344.
The role of ischemic preconditioning in the expression of apoptosis-related genes in a rat model of intestinal ischemia-reperfusion injury.
Miranda C, Fagundes D, Miranda E, Simoes R, Carbonel A, Florencio-Silva R
Acta Cir Bras. 2019; 34(5):e201900501.
PMID: 31166464
PMC: 6583933.
DOI: 10.1590/s0102-865020190050000001.
Effect of the CCL5-Releasing Fibrin Gel for Intervertebral Disc Regeneration.
Zhou Z, Zeiter S, Schmid T, Sakai D, Iatridis J, Zhou G
Cartilage. 2018; 11(2):169-180.
PMID: 29582673
PMC: 7097979.
DOI: 10.1177/1947603518764263.
Epigenetic Modification of the CCL5/CCR1/ERK Axis Enhances Glioma Targeting in Dedifferentiation-Reprogrammed BMSCs.
Chen R, Lee W, Zhang X, Zhang J, Lin S, Xu L
Stem Cell Reports. 2017; 8(3):743-757.
PMID: 28216148
PMC: 5355636.
DOI: 10.1016/j.stemcr.2017.01.016.
Recent Advances in Discovering the Role of CCL5 in Metastatic Breast Cancer.
Khalid A, Wolfram J, Ferrari I, Mu C, Mai J, Yang Z
Mini Rev Med Chem. 2015; 15(13):1063-72.
PMID: 26420723
PMC: 4968951.
DOI: 10.2174/138955751513150923094709.
Macrophage cytokines: involvement in immunity and infectious diseases.
Arango Duque G, Descoteaux A
Front Immunol. 2014; 5:491.
PMID: 25339958
PMC: 4188125.
DOI: 10.3389/fimmu.2014.00491.
Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis.
Lee E, Fertig E, Jin K, Sukumar S, Pandey N, Popel A
Nat Commun. 2014; 5:4715.
PMID: 25178650
PMC: 4351998.
DOI: 10.1038/ncomms5715.
Association between regulated upon activation, normal T cells expressed and secreted (RANTES) -28C/G polymorphism and susceptibility to HIV-1 infection: a meta-analysis.
Gong Z, Tang J, Xiang T, Zhang L, Liao Q, Liu W
PLoS One. 2013; 8(4):e60683.
PMID: 23577146
PMC: 3618220.
DOI: 10.1371/journal.pone.0060683.
CCL5 as a potential immunotherapeutic target in triple-negative breast cancer.
Lv D, Zhang Y, Kim H, Zhang L, Ma X
Cell Mol Immunol. 2013; 10(4):303-10.
PMID: 23376885
PMC: 4003203.
DOI: 10.1038/cmi.2012.69.